Market Overview:
The global migraine market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of migraine, rising awareness about migraines, and technological advancements in migraine treatment. The global migraine market is segmented by type, application, and region. By type, the market is divided into oral medications, injectable medications, nasal sprays, and others (including topical therapies and devices). Oral medications are further sub-segmented into triptans and non-steroidal anti-inflammatory drugs (NSAIDs). Injectable medications are sub-divided into ergot alkaloids and DHEs. Nasal sprays are further classified into triptans and NSAIDs. Others include topical therapies such as lidocaine patches 4% or 2%, occipital nerve stimulation therapy (ONST), transcranial magnetic stimulation therapy (TMS), sphenopalatine ganglion blockades/anesthesia/stellate ganglion blocks etc., which are used for treating chronic migraines that have failed other treatments or for patients who cannot take oral medication because of contraindications or side effects. Triptans accounted for the majority share of the global oral medication segment in 2017 owing to their high efficacy in aborting an attack quickly as well as reducing postdrome symptoms such as fatigue,.
Product Definition:
A migraine is a type of headache that can cause severe pain, usually on one side of the head. The pain is often throbbing and may be accompanied by nausea, vomiting, and sensitivity to light or sound. Migraines are believed to be caused by changes in the blood flow to the brain.
Oral:
Oral is a new term in the migraine market. It means that the drug does not go through the blood brain barrier and can be taken by mouth. This class of drugs was previously called “topicals” because they were applied to the skin, but now are known as “systemic” or “ oral " because they are taken internally.
Injectable:
Injectable is a form of medication which is delivered directly into the blood vessels by the help of injections. In some cases, it may also be administered orally but in most chronic pain-related situations, injections are preferred. The drug works by reducing or eliminating the pain caused due to migraine and other similar conditions through one or more injection every three to four hours as per doctor’s prescription.
The major advantage associated with injectable over oral medications such as tablets.
Application Insights:
Based on application, the global migraine market is segmented into hospitals, clinics and other medical facilities, home care settings and others. Hospitals held the largest share of over 50% in 2017 owing to availability of advanced healthcare services for migraine treatment. Migraine patients prefer to seek treatment at hospitals as they have better access to pain management centers and experienced staff members who can assist them with pain management.
Clinics and other medical facilities are expected to be one of the fastest-growing segments due largely to increasing awareness about effective treatments for migraines along with rising number of such facilities across various regions. For instance, headache clinic at Mayo Clinic in Rochester Minnesota offers a wide range of options including non-invasive procedures like neurostimulators that are used for treating migraines effectively without surgery or any additional procedures during consultation hours. Such initiatives by prominent players in the market are anticipated drive growth over next few years.
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-established healthcare infrastructure, high prevalence of chronic conditions, and availability of effective treatment for migraine are some factors responsible for its large share. In addition, growing awareness about various treatment options is expected to fuel the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing disposable income levels and rising patient awareness regarding available treatments coupled with improving healthcare facilities in emerging countries such as China and India. Moreover, an increase in per capita health expenditure by governments is likely to boost demand for headache medicines due to their affordability; this factor will also contribute toward regional growth over the next eight years.
The introduction of favorable government policies aimed at increasing access & affordability along with a rise in public & private funding initiatives are expected favorably impact Latin America’s market during the same period.
Growth Factors:
- Increasing awareness about migraine and its symptoms
- Rising prevalence of migraine in different population groups
- Growing demand for effective treatment options for migraine
- Availability of new and innovative therapies for migraine
- Increased research and development activities focused on migraines
Scope Of The Report
Report Attributes
Report Details
Report Title
Migraine Market Research Report
By Type
Oral, Injectable, Nasal Sprays, Others
By Application
Hospitals, Clinics, Home Care
By Companies
Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Abbott Laboratories, Johnson & Johnson, Valeant Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Migraine Market Report Segments:
The global Migraine market is segmented on the basis of:
Types
Oral, Injectable, Nasal Sprays, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GlaxoSmithKline
- Allergan
- Amgen
- Eli Lilly
- Teva Pharma
- Biohaven Pharma
- Abbott Laboratories
- Johnson & Johnson
- Valeant Pharma
Highlights of The Migraine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injectable
- Nasal Sprays
- Others
- By Application:
- Hospitals
- Clinics
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Migraine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Migraine is a neurological disorder that affects the brain. It is characterized by severe headache, nausea, vomiting, and sensitivity to light and sound.
Some of the key players operating in the migraine market are Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Abbott Laboratories, Johnson & Johnson, Valeant Pharma.
The migraine market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Migraine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Migraine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Migraine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Migraine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Migraine Market Size & Forecast, 2018-2028
4.5.1 Migraine Market Size and Y-o-Y Growth
4.5.2 Migraine Market Absolute $ Opportunity
Chapter 5 Global Migraine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Migraine Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injectable
5.2.3 Nasal Sprays
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Migraine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Migraine Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Migraine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Migraine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Migraine Analysis and Forecast
9.1 Introduction
9.2 North America Migraine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Migraine Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injectable
9.6.3 Nasal Sprays
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Migraine Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Migraine Analysis and Forecast
10.1 Introduction
10.2 Europe Migraine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Migraine Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injectable
10.6.3 Nasal Sprays
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Migraine Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Migraine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Migraine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Migraine Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injectable
11.6.3 Nasal Sprays
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Migraine Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Migraine Analysis and Forecast
12.1 Introduction
12.2 Latin America Migraine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Migraine Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injectable
12.6.3 Nasal Sprays
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Migraine Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Migraine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Migraine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Migraine Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injectable
13.6.3 Nasal Sprays
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Migraine Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Migraine Market: Competitive Dashboard
14.2 Global Migraine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GlaxoSmithKline
14.3.3 Allergan
14.3.4 Amgen
14.3.5 Eli Lilly
14.3.6 Teva Pharma
14.3.7 Biohaven Pharma
14.3.8 Abbott Laboratories
14.3.9 Johnson & Johnson
14.3.10 Valeant Pharma
